Abstract
Staging laparotomy with splenectomy for Hodgkin’s disease was introduced at Stanford University in the late 1960s as part of ongoing research protocols. It illuminated the patterns of spread of the disease, clarified why many patients with clinically localized disease relapsed after receiving limited radiation therapy, and led to the development of modern treatment protocols, with corresponding improvements in freedom from relapse (FFR) and survival rates for many patients. Recent advances in diagnostic imaging, large studies defining groups of patients at high and low risk for occult subdiaphragmatic disease, cooperative trials demonstrating excellent treatment results for clinically staged patients, and the development of new, effective, and possibly less toxic chemotherapy regimens have challenged oncologists to reexamine the role of staging lapparotomy [1]. Physicians continue to strive to improve cure rates while minimizing the risk of short-and long-term complications due to either staging procedures, initial treatment protocols, or potential second or third treatment regimens.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hoppe RT: Hodgkin’s disease. Patterns of Care Study News 3:1–8, 1990-1991.
Carbone PP, Kaplan HS, Mushoff K, et al.: Report of the committee on Hodgkin’s disease staging classification. Cancer Res 31:1860–1861, 1971.
Crnkovich MJ, Hoppe RT, Rosenberg SA: Stage IIB Hodgkin’s disease: The Stanford experience. J Clin Oncol 4:472–479, 1986.
Gobbi PG, Cavalli C, Gendarini A, et al.: Reevaluation of prognostic significance of symptoms in Hodgkin’s disease. Cancer 56:2876–2880, 1985.
Gobbi PG, Pieresca C, Ricciardi L, et al.: Night sweats in Hodgkin’s disease: A manifestation of preceding minor febrile pulses. Cancer 65:2074–2077, 1990.
Hoppe RT, Castellino RA: The staging of Hodgkin’s disease. In Principles and Practice of Oncology Updates, Vol 4, 1991, p 2.
Roithmann S, Tourani JM, Andrieir JM: Hodgkin’s disease in HIV-infected intravenous drug abusers. N Engl J Med 323:275–276, 1990.
Seviano M, Belles C, Campro E, et al.: Hodgkin’s disease in patients with antibodies to human immunodeficiency virus. Cancer 65:2248–2254, 1990.
Coppleson LW, Factor RM, Strum SB, et al.: Observer disagreement in the classification and histology of Hodgkin’s disease. J Natl Cancer Inst 45:731–740, 1970.
Tubiana M, Hargat M, Henry-Amar M, et al.: Five year results of the EORTC randomized study of splenectomy and spleen irradiation in clinical Stages I and II of Hodgkin’s disease. Eur J Cancer 17:355–363, 1981.
Holman CDJ, Matz LR, Finlay-Jones LR, et al.: Interobserver variation in the histopatho-logical reporting of Hodgkin’s disease: An analysis of diagnostic subcomponents using kappa statistics. Histopathology 7:399–407, 1983.
Tubiana M, Henry-Amar M, Carde P, et al.: Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin’s disease. The EORTC Lymphoma Group controlled clinical trials: 1964–1987. Blood 73:47–56, 1989.
Ray GR, Wolf PH, Kaplan HS: Value of laparotomy studies in Hodgkin’s disease: Preliminary results. Natl Cancer Inst Monogr 36:315–323, 1973.
Castellino RA, Blank N, Hoppe RT, et al.: Hodgkin’s disease: Contribution of chest CT in the initial staging evaluation. Radiology 160:603–605, 1986.
Leibenhaut MH, Hoppe RT, Efron B, et al.: Prognostic indicators of laparotomy findings in clinical Stage I—II supradiaphragmatic Hodgkin’s disease. J Clin Oncol 7:81–91, 1989.
Hoppe RT: The management of bulky mediastinal Hodgkin’s disease. Hematol Oncol Clin North Am 3:265–276, 1989.
Leopold KA, Canellos GP, Rosenthal D, et al.: Stage IA-IIB Hodgkin’s disease: Staging and treatment of patients with large mediastinal adenopathy. J Clin Oncol 8:1059–1065, 1989.
Dowling SW, Peschel RE, Portlock CS, et al.: Mediastinal irradiation in combined modality for Hodgkin’s disease. Int J Radi Oncol Biol Phys 19:543–546, 1990.
Longo DL, Russo A, Duffey PL, et al.: Treatment of advanced-stage massive mediastinal Hodgkin’s disease: The case for combined modality treatment. J Clin Oncol 9:227–235, 1991.
Rostock RA, Siegelmann SS, Lenhard RE, et al.: Thoracic CT scanning for mediastinal Hodgkin’s disease: Results of therapeutic implications. Int J Radiol Oncol Biol Phys 9:1451–1457, 1983.
Hopper KD, Diehl LF, Lesar M, et al.: Hodgkin’s disease: Clinical utility of CT in initial staging and treatment. Radiology 169:17–22, 1988.
Johnston GS, Go MF, Benva RS, et al.: Gallium-67 citrate imaging in Hodgkin’s disease: Final report of cooperative group. J Nucl Med 18:692–698, 1977.
Anderson KC, Leonard RCF, Canellos GP, et al.: High dose gallium imaging in lymphoma. Am J Med 75:327–331, 1983.
Hagemeister FB, Fesus SM, Lamki LM, et al.: Role of the gallium scan in Hodgkin’s disease. Cancer 65:1090–1096, 1990.
Jochelson MS, Kaplan WD, Marcus KC, et al.: Abdominopelvic CT and gallium scanning in staging Hodgkin’s disease: Is laparotomy necessary? Presented at 77th Scientific Assembly and Annual Meeting Radiological Society of North America, 1991.
Castellino RA, Hoppe RT, Blank N, et al.: Computerized tomography, lymphography, and staging laparotomy: Correlations in initial staging of Hodgkin’s disease. AJR 143: 37–41, 1984.
Marglin S, Castellino R: Lymphographic accuracy in 632 consecutive, previously untreated cases of Hodgkin’s disease and non-Hodgkin lymphoma. Radiology 140:351–353, 1981.
Kademian MT, Wintanen GW: Accuracy of bipedal lymphography in Hodgkin’s disease. AJR 129:1041–1042, 1977.
Friedman PA, Sommer FG, Chen HS, et al.: Characterization of splenic structure in Hodgkin’s disease by using narrow-band filtration of back scattered ultrasound. AJR 152:1197, 1989.
Weisslader R, Elizondo G, Stark DD, et al.: The diagnosis of splenic lymphoma by MR imaging: Value of superparamagnetic iron oxide. AJR 152:175–180, 1989.
Shield AF, Porter BA, Churchley S, et al.: The detection of bone marrow involvement by lymphoma using magnetic resonance imaging. J Clin Oncol 5:225–230, 1987.
Glatstein E, Trueblood HW, Enright LP, et al.: Surgical staging of abdominal involvement in unselected patients with Hodgkin’s disease. Radiology 97:425–432, 1970.
Ray GR, Trueblood HL, Enright LP, et al.: Oophoropexy: A means for preserving ovarian function following pelvic megavoltage radiotherapy for Hodgkin’s disease. Radiology 96:175–180, 1970.
Nahhas WA, Nisce LZ, D’Angio GJ, et al.: Lateral ovarian transposition: Ovarian relocation in patients with Hodgkin’s disease. Obstet Gynecol 38:785–788, 1971.
LeFloch O, Donaldson SS, Kaplan HS: Pregnancy following oophoropexy and total nodal irradiation in women with Hodgkin’s disease. Cancer 38:2263–2268, 1976.
Gabriel DA, Bernard SA, Lambert J, et al.: Oophoropexy and the management of Hodgkin’s disease. Arch Surg 121:1083–1085, 1986.
Taylor MA, Kaplan HS, Nelson TS: Staging laparotomy with splenectomy for Hodgkin’s disease: The Stanford experience. World J Surg 9:449–460, 1980.
Brogadir S, Fialk MA, Coleman M, et al.: Mortality of staging laparotomy in Hodgkin’s disease. Am J Med 64:429–433, 1978.
Kaiser CW: Complications of staging laparotomy for Hodgkin’s disease. J Surg Oncol 16:319–325, 1981.
Slavin R, Nelson TS: Complications for staging laparotomy for Hodgkin’s disease. In International Symposium on Hodgkin’s Disease, NCI Monograph 36. Bethesda, MD: US Department of Health, Education and Welfare, 1973, pp 457–459.
Veronesi U, Spinelli P, Bonadonna G, et al.: Laparoscopy and laparotomy in staging Hodgkin’s and non-Hodgkin’s lymphoma. AJR 127:501–503, 1976.
Coker DD, Morris DM, Coleman JJ, et al.: Infection among 210 patients with surgically staged Hodgkin’s disease. Am J Med 75:97–109, 1983.
Desser RK, Ultmann JE: Risk of severe infection in patients with Hodgkin’s disease or lymphoma after diagnostic laparotomy and splenectomy. Ann Intern Med 77:143–146, 1972.
Weitzman S, Aisenberg AC: Fulminant sepsis after successful treatment of Hodgkin’s disease. Am J Med 62:47–50, 1977.
Abrahamsen AF, Borge L, Holte H: Infection after splenectomy for Hodgkin’s disease. Acta Oncol 29:167–170, 1990.
Physicians Desk Reference. Oradell, NJ: Medical Economics Co, 1990, pp 1431–1432.
Van Leeuwan FE, Somers R, Hart AAM: Splenectomy in Hodgkin’s disease and second leukemias. Lancet 8852:210–211, 1987.
Kaldor JM, Day NE, Clarke EA, et al.: Leukemia following Hodgkin’s disease. N Engl J Med 322:7–13, 1990.
Van der Velden JW, Van Putton WLJ, Guinee VF, et al.: Subsequent development of acute non-lymphocytic leukemia in patients treated for Hodgkin’s disease. Int J Cancer 42:252–255, 1988.
Dailey MO, Coleman CN, Fajardo LF: Splenic injury caused by therapeutic irradiation. Am J Surg Pathol 5:325–331, 1981.
Coleman CN, McDougall IR, Dailey MO, et al.: Functional hyposplenia by therapeutic irradiation. Am J Surg Pathol 5:325–331, 1981.
Le Bourgeois JP, Meignan M, Parmentier C, et al.: Renal consequences of irradiation of spleen in lymphomas. Br J Radiol 52:55–60, 1979.
Salzman JR, Kaplan HS: Effect of prior splenectomy on hematological tolerance during total lymphoid radiotherapy of patients with Hodgkin’s disease. Cancer 27:471–478, 1971.
Schreiber DP, Jacobs C, Rosenberg SA, et al.: The potential benefits of therapeutic splenectomy for patients with Hodgkin’s disease and non-Hodgkin’s lymphoma. Int J Radiat Oncol Biol Phys 11:31–36, 1985.
Brada M, Easton DF, Horwich A, et al.: Clinical presentation as a predictor of laparotomy findings in supradiaphragmatic Stage I and II Hodgkin’s disease. Radiother Oncol 5:15–22, 1986.
de la Cruz BA, Cardenes H, Otero J, et al.: Individual risk of abdominal disease in patients with Stage I and II supradiaphragmatic Hodgkin’s disease: A rule index based on 341 laparotomized patients. Cancer 63:1799–1803, 1989.
Mauch P, Lason D, Osteen R, et al.: Prognostic factors for positive surgical staging in patients with Hodgkin’s disease. J Clin Oncol 8:257–265, 1989.
Leibenhaut MH, Hoppe RT, Varghese A, et al.: Subdiaphragmatic Hodgkin’s disease: Laparotomy and treatment results in 49 patients. J Clin Oncol 5:1050–1055, 1987.
Brogadir S, Fialk MA, Coleman M, et al.: Morbidity of staging laparotomy in Hodgkin’s disease. Am J Med 64:429–433, 1978.
Abrahamsen AF, Host H, Jorgenson OG: Is staging laparotomy of therapeutic value in patients with supradiaphragmatic Hodgkin’s disease, clinical Stage IA-IIA? Scand J Haematol 25:439–444, 1980.
Askergren J, Bjorkholm M, Holm G, et al.: Prognostic effect of early diagnostic splenectomy in Hodgkin’s disease: A randomized trial. Br J Cancer 42:284–291, 1980.
Bergesel DE, Alison RE, Bean HA, et al: Results of treating Hodgkin’s disease without a policy of laparotomy staging. Cancer Treat Rep 66:717–731, 1982.
Worthy JS: Evaluation of diagnostic laparotomy and splenectomy in Hodgkin’s disease (rep 12). Clin Radiol 32:523–526, 1981.
Sutcliffe SB, Gospodarowicz MK, Bergasel DE, et al.: Prognostic groups for management of localized Hodgkin’s disease. J Clin Oncol 3:393–401, 1985.
Tubiana M, Henry-Amar M, Hyat M, et al.: The EORTC treatment of early stages of Hodgkin’s disease: The role of radiotherapy. Int J Radiat Oncol Biol Phys 10:197–210, 1984.
Mauch P, Tarbell N, Weinstein H, et al.: Stage IA and IIA supradiaphragmatic Hodgkin’s disease: Prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation. J Clin Oncol 6:1576–1583, 1988.
Hoppe RT, Cox RS, Rosenberg SA, et al.: Prognostic factors in pathologic stage III Hodgkin’s disease. Cancer Treat Rep 66:743–749, 1982.
Mauch P, Goffman T, Rosenthal DS, et al.: Stage III Hodgkin’s disease: Improved survival with combined modality therapy as compared with radiation therapy alone. J Clin Oncol 3:1166–1173, 1985.
Hoppe RT, Horning SJ, Rosenberg SA: The concept, evolution and preliminary results of current Stanford clinical trials for Hodgkin’s disease. Cancer Surv 4, 1985.
Hagemeister FB, Fuller LM, Sullivan JA, et al.: Treatment of patients with Stages I and II nonmediastinal Hodgkin’s disease. Cancer 50:2307–2313, 1982.
Haybittle JL, Easterling MJ, Bennett MH, et al.: Review of British National Lymphoma Investigation Studies of Hodgkin’s disease and development of prognostic index. Lancet 967–972, 1985.
Carde P, Burgess JMV, Henry-Amar M, et al.: Clinical Stages I and II Hodgkin’s disease: A specifically tailored therapy according to prognostic factors. J Clin Oncol 6:239–252, 1988.
Kinzie JJ, Hanks GE, Maclean CJ, et al.: Patterns of Care Study: Hodgkin’s disease relapse rates and adequacy of portals. Cancer 52:2223–2226, 1983.
Hanks GE, Kinzie JJ, White RL, et al.: Patterns of Care Outcome Studies: Results of the national practice in Hodgkin’s disease. Cancer 51:569–573, 1983.
Hanks GE, Kinzie JJ, Herring DF, et al.: Patterns of Care Outcome Studies in Hodgkin’s disease: Results of national practice and implications for management. Cancer Treat Rep 66:805–808, 1972.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Leibenhaut, M.H. (1993). The changing role of staging laparotomy in the management of Hodgkin’s disease. In: Dana, B.W. (eds) Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems. Cancer Treatment and Research, vol 66. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3084-8_1
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3084-8_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6347-7
Online ISBN: 978-1-4615-3084-8
eBook Packages: Springer Book Archive